Lineage Cell Therapeutics, Inc. Made Headway
Fri, Apr 30, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) shot up at $49.8, a gain of 45.5%. The stock got featured on our News Catalysts scanner on Thu, Apr 29, 2021 at 10:01 AM in the 'BIOTECH' category. From Thu, Apr 15, 2021, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Wed, Apr 28, 2021 at $54.24 with a volume of 51M+.
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 45.53%
- Image Sensing Systems, Inc. (ISNS:NASDAQ), 42.05%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 38.05%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 27.52%
- Farmmi, Inc. (FAMI:NASDAQ), 24.58%
- CryoLife, Inc. (CRY:NYSE), 24.22%
- SunLink Health Systems, Inc. (SSY:NYSEMKT), 23.21%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 17.91%
- Vaxart, Inc. (VXRT:NASDAQ), 17.05%
- Shineco, Inc. (TYHT:NASDAQ), 16.53%